Boston Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q3 | $368K | Sell |
2,870
-24,417
| -89% | -$3.13M | 0.02% | 493 |
|
2019
Q2 | $3.89M | Sell |
27,287
-15,392
| -36% | -$2.19M | 0.21% | 135 |
|
2019
Q1 | $6.1M | Buy |
42,679
+36,651
| +608% | +$5.24M | 0.31% | 89 |
|
2018
Q4 | $747K | Sell |
6,028
-4,795
| -44% | -$594K | 0.04% | 385 |
|
2018
Q3 | $1.82M | Buy |
10,823
+2,400
| +28% | +$404K | 0.08% | 295 |
|
2018
Q2 | $1.45M | Buy |
8,423
+5,433
| +182% | +$936K | 0.04% | 310 |
|
2018
Q1 | $451K | Sell |
2,990
-250
| -8% | -$37.7K | 0.01% | 513 |
|
2017
Q4 | $436K | Sell |
3,240
-300
| -8% | -$40.4K | 0.01% | 519 |
|
2017
Q3 | $518K | Hold |
3,540
| – | – | 0.01% | 488 |
|
2017
Q2 | $550K | Sell |
3,540
-50
| -1% | -$7.77K | 0.01% | 468 |
|
2017
Q1 | $521K | Sell |
3,590
-950
| -21% | -$138K | 0.01% | 455 |
|
2016
Q4 | $495K | Sell |
4,540
-72,953
| -94% | -$7.95M | 0.01% | 481 |
|
2016
Q3 | $9.41M | Sell |
77,493
-83,825
| -52% | -$10.2M | 0.23% | 135 |
|
2016
Q2 | $22.8M | Buy |
161,318
+133,038
| +470% | +$18.8M | 0.57% | 41 |
|
2016
Q1 | $3.69M | Buy |
28,280
+1,735
| +7% | +$227K | 0.09% | 220 |
|
2015
Q4 | $3.73M | Sell |
26,545
-6,650
| -20% | -$935K | 0.09% | 228 |
|
2015
Q3 | $4.41M | Sell |
33,195
-10,220
| -24% | -$1.36M | 0.17% | 185 |
|
2015
Q2 | $7.64M | Sell |
43,415
-1,195
| -3% | -$210K | 0.32% | 101 |
|
2015
Q1 | $7.71M | Sell |
44,610
-660
| -1% | -$114K | 0.3% | 106 |
|
2014
Q4 | $7.41M | Buy |
45,270
+8,735
| +24% | +$1.43M | 0.31% | 97 |
|
2014
Q3 | $5.87M | Sell |
36,535
-8,175
| -18% | -$1.31M | 0.25% | 118 |
|
2014
Q2 | $6.57M | Buy |
44,710
+1,360
| +3% | +$200K | 0.28% | 104 |
|
2014
Q1 | $6.01M | Sell |
43,350
-26,071
| -38% | -$3.62M | 0.27% | 107 |
|
2013
Q4 | $8.79M | Sell |
69,421
-7,509
| -10% | -$950K | 0.42% | 81 |
|
2013
Q3 | $7.08M | Buy |
76,930
+36,340
| +90% | +$3.34M | 0.38% | 87 |
|
2013
Q2 | $2.79M | Buy |
+40,590
| New | +$2.79M | 0.13% | 138 |
|